# Liminatus Pharma, Inc.: Form SCHEDULE 13D/A, filed Jul 14, 2026

- Company: [Liminatus Pharma, Inc.](/companies/limn.md) (CIK 1971387)
- Form: SCHEDULE 13D/A
- Filed: 2026-07-14
- Accepted by EDGAR: Jul 14, 2026, 17:36 ET
- Period: not reported
- Accession: 0001104659-26-083585
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1971387/000110465926083585/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1971387/000110465926083585/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1971387/000110465926083585/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Jul 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-083585. Last ingested by Listed: Nov 3, 2026, 19:32 ET. No prices; not investment advice.